Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT00840047 : Methionine PET/CT Studies In Patients With Cancer
PhaseN/A
AgesMin: N/A Max: N/A
Eligibility
Inclusion Criteria:

- All participants under the care of St. Jude physicians with known or suspected
neoplastic disease are eligible for participation.

- Participants will have had, or are scheduled to have clinical imaging evaluations
which may include FDG PET CT, or CT, or MRI within 4 weeks of entry.

- No limit on age or gender.

- Female participants of childbearing age must not be lactating due to theoretical
potential harm to the infant from exposure to radiation.

- Informed consent signed by participant, parent, or guardian according to the
guidelines of the institutional review board.

Exclusion Criteria:

- More than 6 MET PET scans within the previous 12 months.

- Inability or unwillingness of research participant, parent, or legal
guardian/representative to give written informed consent.
LinksPermanent Link to THIS page: http://virtualtrials.com/nct/display1trial.cfm?nct=NCT00840047      |      Link to official Clinicaltrials.gov listing
Locations
Memphis, Tennessee
Facility: St. Jude Children's Research Hospital
Investigator: Barry L Shulkin, MD
Contact: Barry L Shulkin, MD Phone: 866-278-5833
Click HERE to send email to this center




Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites